Global Seasonal Influenza Vaccine Market Overview And Scope:
Global Seasonal Influenza Vaccine Market Size was estimated at USD 4133.3 million in 2022 and is projected to reach USD 4687.99 million by 2028, exhibiting a CAGR of 2.12% during the forecast period.
The Global Seasonal Influenza Vaccine Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Seasonal Influenza Vaccine utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: GSK, Sinovac, Changsheng, CCBIO, Aleph Biomedical, Sanofi, Lanzhou Institute Of Biological Product, Siobp, Hualan Bio, Tianyuan Bio-Pharma, Vaxtec, Hissen, Abbott, Novartis, TaslyandJenner, Tiantan
Global Seasonal Influenza Vaccine Market Segmentation
By Type, Seasonal Influenza Vaccine market has been segmented into:Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other
By Application, Seasonal Influenza Vaccine market has been segmented into:
Children
Adults
Elderly
Pregnancy
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Seasonal Influenza Vaccine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Seasonal Influenza Vaccine market.
Top Key Players Covered in Seasonal Influenza Vaccine market are:
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
TaslyandJenner
Tiantan
Objective to buy this Report:
1. Seasonal Influenza Vaccine analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Seasonal Influenza Vaccine market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Seasonal Influenza Vaccine Market by Type
5.1 Seasonal Influenza Vaccine Market Overview Snapshot and Growth Engine
5.2 Seasonal Influenza Vaccine Market Overview
5.3 Trivalent Influenza Vaccine
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Trivalent Influenza Vaccine: Geographic Segmentation
5.4 Quadrivalent Influenza Vaccine
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Quadrivalent Influenza Vaccine: Geographic Segmentation
5.5 Other
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Other: Geographic Segmentation
Chapter 6: Seasonal Influenza Vaccine Market by Application
6.1 Seasonal Influenza Vaccine Market Overview Snapshot and Growth Engine
6.2 Seasonal Influenza Vaccine Market Overview
6.3 Children
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Children: Geographic Segmentation
6.4 Adults
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Adults: Geographic Segmentation
6.5 Elderly
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Elderly: Geographic Segmentation
6.6 Pregnancy
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Pregnancy: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Seasonal Influenza Vaccine Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Seasonal Influenza Vaccine Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Seasonal Influenza Vaccine Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 GSK
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 SINOVAC
7.4 CHANGSHENG
7.5 CCBIO
7.6 ALEPH BIOMEDICAL
7.7 SANOFI
7.8 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
7.9 SIOBP
7.10 HUALAN BIO
7.11 TIANYUAN BIO-PHARMA
7.12 VAXTEC
7.13 HISSEN
7.14 ABBOTT
7.15 NOVARTIS
7.16 TASLYANDJENNER
7.17 TIANTAN
Chapter 8: Global Seasonal Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Trivalent Influenza Vaccine
8.2.2 Quadrivalent Influenza Vaccine
8.2.3 Other
8.3 Historic and Forecasted Market Size By Application
8.3.1 Children
8.3.2 Adults
8.3.3 Elderly
8.3.4 Pregnancy
Chapter 9: North America Seasonal Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Trivalent Influenza Vaccine
9.4.2 Quadrivalent Influenza Vaccine
9.4.3 Other
9.5 Historic and Forecasted Market Size By Application
9.5.1 Children
9.5.2 Adults
9.5.3 Elderly
9.5.4 Pregnancy
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Seasonal Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Trivalent Influenza Vaccine
10.4.2 Quadrivalent Influenza Vaccine
10.4.3 Other
10.5 Historic and Forecasted Market Size By Application
10.5.1 Children
10.5.2 Adults
10.5.3 Elderly
10.5.4 Pregnancy
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Seasonal Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Trivalent Influenza Vaccine
11.4.2 Quadrivalent Influenza Vaccine
11.4.3 Other
11.5 Historic and Forecasted Market Size By Application
11.5.1 Children
11.5.2 Adults
11.5.3 Elderly
11.5.4 Pregnancy
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Seasonal Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Trivalent Influenza Vaccine
12.4.2 Quadrivalent Influenza Vaccine
12.4.3 Other
12.5 Historic and Forecasted Market Size By Application
12.5.1 Children
12.5.2 Adults
12.5.3 Elderly
12.5.4 Pregnancy
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Seasonal Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Trivalent Influenza Vaccine
13.4.2 Quadrivalent Influenza Vaccine
13.4.3 Other
13.5 Historic and Forecasted Market Size By Application
13.5.1 Children
13.5.2 Adults
13.5.3 Elderly
13.5.4 Pregnancy
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Seasonal Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Trivalent Influenza Vaccine
14.4.2 Quadrivalent Influenza Vaccine
14.4.3 Other
14.5 Historic and Forecasted Market Size By Application
14.5.1 Children
14.5.2 Adults
14.5.3 Elderly
14.5.4 Pregnancy
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Seasonal Influenza Vaccine Scope:
|
Report Data
|
Seasonal Influenza Vaccine Market
|
|
Seasonal Influenza Vaccine Market Size in 2025
|
USD XX million
|
|
Seasonal Influenza Vaccine CAGR 2025 - 2032
|
XX%
|
|
Seasonal Influenza Vaccine Base Year
|
2024
|
|
Seasonal Influenza Vaccine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GSK, Sinovac, Changsheng, CCBIO, Aleph Biomedical, Sanofi, Lanzhou Institute Of Biological Product, Siobp, Hualan Bio, Tianyuan Bio-Pharma, Vaxtec, Hissen, Abbott, Novartis, TaslyandJenner, Tiantan.
|
|
Key Segments
|
By Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other
By Applications
Children
Adults
Elderly
Pregnancy
|
